{"result": "(\"entity\"<|>GLUCEMIA<|>EVENT<|>Glucemia refers to the level of glucose in the blood, which is a critical factor in managing diabetes.)\n##\n(\"entity\"<|>CETOACIDOSIS<|>EVENT<|>Cetoacidosis is a serious complication of diabetes that occurs when the body produces high levels of ketones, often due to insufficient insulin.)\n##\n(\"entity\"<|>HIPOGLOCEMIAS<|>EVENT<|>Hipoglucemias are episodes of low blood sugar that can occur in diabetes management, particularly with insulin therapy.)\n##\n(\"entity\"<|>ALIMENTACIÓN<|>EVENT<|>Alimentación refers to dietary habits and intake, which are crucial in managing diabetes and related eating disorders.)\n##\n(\"entity\"<|>ANALÍTICA<|>EVENT<|>Analítica refers to the laboratory tests conducted to monitor the patient's health status, particularly in relation to diabetes management.)\n##\n(\"entity\"<|>HBA1C<|>EVENT<|>HbA1C is a blood test that measures average blood glucose levels over the past 2 to 3 months, important for diabetes management.)\n##\n(\"relationship\"<|>PACIENTE<|>GLUCEMIA<|>The patient's blood glucose levels (glucemia) are monitored as part of her diabetes management<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>CETOACIDOSIS<|>The patient experienced cetoacidosis due to poor management of her diabetes<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>HIPOGLOCEMIAS<|>The patient has experienced episodes of hipoglucemias as a result of her diabetes treatment<|>6)\n##\n(\"relationship\"<|>PACIENTE<|>ALIMENTACIÓN<|>The patient's dietary habits (alimentación) are directly impacting her diabetes management and eating disorder<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>ANALÍTICA<|>The patient's health status is assessed through analítica, which includes tests relevant to her diabetes<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>HBA1C<|>The patient's HbA1C levels are monitored to evaluate her long-term glucose control<|>9)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: insulina glulisina mediante ISCI, con lo que logra\n    HbA1C:7.3% con escasas hipoglucemias leves.\n\n\n\n             En ese momento la paciente deja voluntariamente de acudir a revisiones siendo\n    controlada en un Centro Privado.\n\n\n\n             En mayo 2016 precisa reingreso hospitalario por Glucemia>400 con cetonuria\n    intensa, pH: 7.34 y HbA1C 9.6%; el peso se ha mantenido pero la conducta alimentaria\n    y el autocuidado de la DM están totalmente desestructurados. La familia se encuentra\n    desbordada y se decide nuevo ingreso en Hospital de día UTCA para estabilización de\n    conducta alimentaria y cifras de glucemia. En ese momento la analítica es normal\n    salvo Mg (1.5mg/dL) y VitD (12.3mg/dL). Al alta en agosto 2016 presenta HbA1C 8.8%\n    61Kg IMC 20.7, con estabilidad de la conducta alimentaria pero por rechazo de la pacien-\n    te se retira ISCI y pasa a multidosis (Degludec + glulisina) Además recibe Venlafaxina\n    75mg/día y VitD3 50000UI/mes.\n\n\n\n             Durante el periodo 2016-18 como resumen: HbA1C: 8-9%. Resto de parámetros\n    analíticos dentro de lo normal. No precisa ingresos. No vómitos, pero sí persiste omi-\n    sión dosis insulina como método para mantener el peso. No mantiene la restricción\n    alimentaria o los episodios de atracones. Hipoglucemias ocasionales no graves.\n\n\n\n             En la última revisión en consulta (16/04/18): HbA1C 7.4%, resto normal. Mejor\n    control glucémico al instaurar uso de monitorización flash de glucosa. Pesa 61.9Kg\n    (IMC 20.9) No presenta complicaciones crónicas. Hipoglucemias ocasionales (menor\n    número y severidad que antes). En cuanto a la omisión dosis insulina para control del\n    peso, es menos frecuente, pero persiste.\n\n\n\n88\n---\nDiscusión\n         Este caso ilustra la dificultad de tratar dos enfermedades en la misma paciente\ncuando las recomendaciones de tratamiento de cada una de ellas pueden resultar con-\ntraproducentes para la otra: el control de las raciones de hidratos de carbono preciso\npara controlar la glucemia dificulta el avance en el manejo de la restricción alimentaria\ndel TCA; la intensificación del tratamiento insulínico favorece la ganancia de peso y las\nhipoglucemias que, pueden a su vez, dificultar el control de las conductas de atracón7 .\nAdemás, las pacientes diabéticas tipo 1 presentan una forma específica de conducta\ncompensadora o de purga: la omisión de dosis de insulina8, que aunque menos llamativa\nque los vómitos y otras maniobras compensadoras puede ser tan peligrosa o más para\nla salud de las pacientes6 , aumentando tanto la tasa de complicaciones de la diabetes 5\ncomo la mortalidad. Además la omisión de insulina como purga es la medida que más\nse mantiene en el tiempo afectando a gran número de mujeres DM1 jóvenes, no solo\nadolescentes, llegando en algunas series a ser casi el 40% de la población estudiada7,9 .\n         Estas características especiales de los TCA en DM1 hacen que sea necesario\nimpulsar el desarrollo de herramientas específicas de cribado en este grupo de pa-\ncientes10,11 , test que recojan mejor las características y relación con la restricción de\ndeterminados grupos alimentarios en este grupo de pacientes, la omisión de dosis de\ninsulina o las variaciones de peso en relación con el grado de control o tipo de trata-\nmiento de la diabetes.\n\n\n\n         En cuanto al tratamiento de los pacientes con TCA y DM1, no existen recomen-\ndaciones específicas aunque la mayoría de las revisiones sobre el tema sugieren la ne-\ncesidad de un equipo multidisciplinar (psiquiatra, psicólogo, endocrinólogo, educador\nde diabetes, dietista/nutricionista y trabajador social) con una comunicación frecuente\ny fluida entre ellos para modificar y reajustar las prioridades de tratamiento según la\nevolución del paciente12 : en un primer momento, el tratamiento intensivo de la DM1 no\nparece adecuado. Se comenzará por estabilizar al paciente (evitar hipoglucemias por\nrestricción de ingesta, minimizar los episodios de cetoacidosis por omisión de insulina,\nestabilizar los electrolitos en caso de vómitos o laxantes) para posteriormente ir avan-\nzando en el control más estrecho de las glucemia. Es también aconsejable advertir a\nlos pacientes de los posibles cambios con la intensificación\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>ISCI<|>ORGANIZATION<|>ISCI is an organization involved in the management of diabetes treatment, specifically related to insulin therapy.)\n##\n(\"entity\"<|>HOSPITAL DE DÍA UTCA<|>ORGANIZATION<|>Hospital de Día UTCA is a facility where patients are stabilized for behavioral and dietary issues related to diabetes management.)\n##\n(\"entity\"<|>VENLAFAXINA<|>ORGANIZATION<|>Venlafaxina is a medication prescribed to manage symptoms related to mental health, often used in conjunction with diabetes treatment.)\n##\n(\"entity\"<|>PACIENTE<|>PERSON<|>The patient is a female individual managing both diabetes and an eating disorder, facing challenges in treatment adherence and dietary control.)\n##\n(\"entity\"<|>DIABETES MELLITUS TIPO 1<|>EVENT<|>Diabetes Mellitus Tipo 1 is a chronic condition that requires careful management of insulin and dietary intake.)\n##\n(\"entity\"<|>TCA<|>EVENT<|>TCA refers to eating disorders that complicate the management of diabetes, particularly in young women.)\n##\n(\"relationship\"<|>PACIENTE<|>HOSPITAL DE DÍA UTCA<|>The patient was admitted to Hospital de Día UTCA for stabilization of her eating behavior and blood glucose levels<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>ISCI<|>The patient is under the care of ISCI for diabetes management, specifically regarding insulin therapy<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>VENLAFAXINA<|>The patient is prescribed Venlafaxina to help manage her mental health issues related to her diabetes and eating disorder<|>6)\n##\n(\"relationship\"<|>DIABETES MELLITUS TIPO 1<|>PACIENTE<|>The patient is diagnosed with Diabetes Mellitus Tipo 1, which requires ongoing treatment and management<|>9)\n##\n(\"relationship\"<|>TCA<|>PACIENTE<|>The patient is struggling with an eating disorder (TCA) that complicates her diabetes management<|>8)\n<|COMPLETE|>"}]}